KDM6A and urinary bladder carcinoma: We recently developed mucoadhesive nanoparticles for intravesical delivery of lysine-specific demethylase 6A (KDM6A) mRNA to overcome physiological bladder barriers for treatment of bladder cancer metastasis [2].